Total mortality · adults with hypertension (patients with atrial fibrillation, congestive heart failure, pre‐eclampsia or pulmonary hypertension were…
Aspirin showed no clear difference in total mortality compared with placebo (low certainty).
1 finding from 1 review
Cardiovascular mortality · adults with hypertension (patients with atrial fibrillation, congestive heart failure, pre‐eclampsia or pulmonary hypertension were…
Aspirin showed no clear difference in cardiovascular mortality compared with placebo (low certainty).
1 finding from 1 review
Non‐fatal cardiovascular events · adults with hypertension (patients with atrial fibrillation, congestive heart failure, pre‐eclampsia or pulmonary hypertension were…
Aspirin may leads to lower non‐fatal cardiovascular events compared with placebo (low certainty).
1 finding from 1 review
Major bleedinga · adults with hypertension (patients with atrial fibrillation, congestive heart failure, pre‐eclampsia or pulmonary hypertension were…
Aspirin leads to higher major bleedinga compared with placebo (high certainty).
1 finding from 1 review
Cardiovascular events · adults with hypertension (patients with atrial fibrillation, congestive heart failure, pre‐eclampsia or pulmonary hypertension were…
Aspirin may leads to lower all cardiovascular events compared with placebo (low certainty).
1 finding from 1 review
Graft thrombosis (up to 18 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
Aspirin showed no clear difference in graft thrombosis (28 days to 18 months) compared with placebo (low certainty).
1 finding from 1 review
Length of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Complications (28 days to 18 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
1 finding from 1 review
Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth rate · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
It is very uncertain whether aspirin changes live birth rate compared with control (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
It is very uncertain whether aspirin changes clinical pregnancy rate compared with control (very low certainty).
1 finding from 1 review
Miscarriage · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Multiple pregnancy rate · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cycle cancellation rate · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Endometrial thickness (mm) · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
1 finding from 1 review
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
Heparin plus aspirin may leads to higher live birth compared with aspirin (low certainty).
1 finding from 1 review
Pre‐eclampsia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
Heparin plus aspirin showed no clear difference in pre‐eclampsia compared with aspirin (low certainty).
1 finding from 1 review
Adverse events in the mother ‐ Bleeding · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
Heparin plus aspirin showed no clear difference in adverse events in the mother ‐ Bleeding compared with aspirin (low certainty).
1 finding from 1 review
Heparin‐induced thrombocytopaenia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review